| For: | Semb S, Helgstrand F, Hjørne F, Bytzer P. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication. World J Gastroenterol 2017; 23(37): 6907-6910 [PMID: 29085234 DOI: 10.3748/wjg.v23.i37.6907] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i37/6907.htm |
| Number | Citing Articles |
| 1 |
R. Kettritz, F. C. Luft. Seltene Elektrolytstörungen. Der Nephrologe 2019; 14(2) doi: 10.1007/s11560-018-0278-7
|
| 2 |
嘉豪 李. Common Adverse Reactions and Corresponding Management Measures of Cisplatin Combined with Gemcitabine in Chemotherapy. Advances in Clinical Medicine 2023; 13(12) doi: 10.12677/ACM.2023.13122684
|
| 3 |
Zuber Khan, Sidharth Mehan, Mohd. Anas Saifi, Ghanshyam Das Gupta, Acharan S. Narula, Reni Kalfin. Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the
Dementia Connection and Co-morbid Risks. Current Alzheimer Research 2023; 20(11) doi: 10.2174/0115672050289946240223050737
|
| 4 |
Rohit Tayal, Sabina Yasmin, Samrat Chauhan, Thakur Gurjeet Singh, Monika Saini, Eman Shorog, Maryam M. Althubyani, Baiaan H. Alsaadi, Fatimah Aljohani, Maram A. Alenazi, Sarah A. Abutaily, Mohammad Yousuf Ansari. Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?. Pharmaceuticals 2023; 16(10) doi: 10.3390/ph16101387
|
| 5 |
|
| 6 |
Lijo James, Gautham Rajan, Deepak Devarajan, Aiswarya Mohan. Neurological Manifestations Associated With Hypomagnesemia Due to Proton-Pump Inhibitors: A Case Series. Cureus 2025; doi: 10.7759/cureus.78229
|
| 7 |
Ho Seok Seo, Miyoung Choi, Sang-Yong Son, Min Gyu Kim, Dong-Seok Han, Han Hong Lee. Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018. Journal of Gastric Cancer 2018; 18(4) doi: 10.5230/jgc.2018.18.e41
|
| 8 |
Pim M. W. Janssens, Michiel W. Pot, Moniek Wouters, Henk J. van Leeuwen, Marcel M. G. J. van Borren. What extreme laboratory values can be obtained that (some) patients can survive with?. Scandinavian Journal of Clinical and Laboratory Investigation 2022; 82(1) doi: 10.1080/00365513.2021.2015800
|
| 9 |
Arun Koyyada. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations. Therapies 2021; 76(1) doi: 10.1016/j.therap.2020.06.019
|
| 10 |
Jinfeng Zhang, Mingxi Lin, Yizi Jin, Linhan Gu, Ting Li, Baoying Yuan, Biyun Wang, Leiping Wang, Sheng Zhang, Jun Cao, Zhonghua Tao, Jian Zhang, Xichun Hu. Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia. Breast Cancer Research and Treatment 2020; 182(3) doi: 10.1007/s10549-020-05730-2
|
| 11 |
Paola Cabras, Michele Anedda, Laura Caddeo, Marongiu Francesco, Mameli Antonella. Hypomagnesemia and Hypocalcemia Caused by Proton-Pump Inhibitors Long-Term Therapy. American Journal of Therapeutics 2020; 27(6) doi: 10.1097/MJT.0000000000001041
|